
Closed
Chair: GlaxoSmithKline Partnered (2012)
Long-term research chair support for academic institutions
Offered by Official source: researchnet-recherchenet.ca
Canadian Institutes of Health Research (CIHR)
Record updated
- Funding available
- Varies by project
- Deadline
- Unspecified
- Location
- Canada
Overview
Chair: GlaxoSmithKline Partnered (2012) was a CIHR and GlaxoSmithKline initiative co-funding long-term research chair awards for candidates nominated by participating academic institutions, with CIHR salary support of up to $375,000 over five years and operating support also available. Supported research included respiratory medicine, virology, oncology, and clinical and translational research.
At a glance
Funding available
Varies by project
- Develop strategic partnerships
- Attract or retain talent
- Conduct research and development activities
- Develop workforce skills
Eligible candidates
- Location
- Canada
- Eligible Industries
- All industries
- Annual revenue
- All revenue ranges
- Organisation size
- All organization sizes
- Audience
- All groups
- Legal structures
- All legal structures
Receipt of requests is now closed
Get notified about updates to this grant.
Availability timeline
2026
Periods: 2
Eligibility
Who is eligible?
- Independent researchers registered at a CIHR-eligible institution.
- Candidates nominated by a CIHR-eligible university and/or hospital participating in the GSK endowment fund program for the purpose of supporting the award.
Who is not eligible
- Candidates who have, are receiving, or are guaranteed salary support by the nominating institution through the GSK endowment, except for renewal chairs.
- Candidates holding a Canada Research Chair, another federally funded Chair, or a major personnel salary award at the same time.
Ineligible Costs and Activities
- CIHR funds may not be used to contribute directly to an endowment fund.
Activities funded
- Research in therapeutic areas including metabolic diseases, respiratory medicine, virology, oncology, and vaccines.
- Research in fields related to development and commercialization, including pharmaceutics, clinical pharmacology, functional genomics, and structural biology.
- Research in emerging areas, including social sciences such as health outcomes.
- Clinical and translational research.
How to apply
- GSK must inform CIHR in writing of any upcoming application at least one month before the application deadline.
- Submit the application through ResearchNet, scanning and uploading the signed signature pages, including the routing slip, in the Print/Upload Signature Pages task before submission.
Documents Needed
- A written institutional commitment letter from the Dean of Faculty or Research Director.
- A five-year research plan.
- A Partner Letter explaining the partner’s involvement and the project’s relevance and potential benefits.
- Signed signature pages, including the routing slip.
- A written letter from GSK notifying CIHR of an upcoming application.
Selection criteria
- Applicant Track Record.
- Research Plan.
- Environment and Support.
- Applications that receive a rating below 3.5 will not be funded.
Processing and Agreement
- A CIHR review committee evaluates the full applications.
- After peer review, CIHR receives the rankings, ratings, and recommendations on funding level and award term for applications in the fundable range that are relevant to the initiative’s research areas and objectives, and uses these for funding decisions.
- The award must be accepted within 15 working days of the offer date or it will be cancelled.
- Award recipients must confirm that they are guaranteed an appointment for the full duration of the award.
- The Nominated Principal Applicant must participate in program monitoring and evaluation activities and provide data or reports as required.
Contacts
Official sources
Frequently Asked Questions about the Chair: GlaxoSmithKline Partnered (2012) Program
What is the Chair: GlaxoSmithKline Partnered (2012)?
Chair: GlaxoSmithKline Partnered (2012) was a CIHR and GlaxoSmithKline initiative co-funding long-term research chair awards for candidates nominated by participating academic institutions, with CIHR salary support of up to $375,000 over five years and operating support also available. Supported research included respiratory medicine, virology, oncology, and clinical and translational research.
Who is eligible for the Chair: GlaxoSmithKline Partnered (2012) program?
To be eligible for the Chair: GlaxoSmithKline Partnered (2012) program, you must:
The Nominated Principal Applicant must be an independent researcher.
The Nominated Principal Applicant must be registered at an eligible institution.
The candidate must be nominated by a participating CIHR-eligible academic institution.
Who can I contact for more information about the Chair: GlaxoSmithKline Partnered (2012)?
You can contact Canadian Institutes of Health Research (CIHR) by email at Chairs-Chaires@cihr-irsc.gc.ca or by phone at 613-957-6123.
Where is the Chair: GlaxoSmithKline Partnered (2012) available?
The Chair: GlaxoSmithKline Partnered (2012) program is available across Canada.
Is the Chair: GlaxoSmithKline Partnered (2012) a grant, loan, or tax credit?
Chair: GlaxoSmithKline Partnered (2012) is a Grant and Funding
Who are the financial supporters of the Chair: GlaxoSmithKline Partnered (2012)?
Chair: GlaxoSmithKline Partnered (2012) is funded by Canadian Institutes of Health Research (CIHR)
